U.S. Markets open in 7 hrs 49 mins

Protagenic Therapeutics, Inc. (PTIX)


Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
2.000.00 (0.00%)
At close: 3:50PM EDT

Protagenic Therapeutics, Inc.

149 Fifth Avenue
Suite 500
New York, NY 10010
United States
212-994-8200
http://www.protagenic.com

SectorTechnology
IndustryNetworking & Communication Devices
Full Time Employees

Key Executives

NameTitlePayExercisedAge
Dr. Garo H. Armen Ph.D.Exec. Chairman of DirectorsN/AN/A64
Dr. Alexander K. Arrow M.D., CFAChief Financial Officer, Compliance Officer and Sec.106.55kN/A46
Dr. Dalia Barsyte Ph.D.Chief Technology AdvisorN/AN/AN/A
Dr. David A. Lovejoy Ph.D.Chief Scientific AdvisorN/AN/AN/A
Ms. Christina Fam FaragallaDirector of Project ManagementN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Protagenic Therapeutics, Inc., a biotechnology company, engages in the discovery and development of therapeutics to treat central nervous system disorders. Its lead drug candidate is PT00114, which is in clinical proof-of-concept studies for the treatment-resistant depression and/or post-traumatic stress disorder. The company is based in New York, New York.

Corporate Governance

Protagenic Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.